HYPERION DEFI, INC. Net Income
HYPERION DEFI, INC. (HYPD) reported Net Income of $30.95 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2026-08-13
- HYPERION DEFI, INC. net income (loss) attributable to parent for the quarter ending 2026-06-30 was $30.95M.
- HYPERION DEFI, INC. net income (loss) attributable to parent for the quarter ending 2026-03-31 was $8.84M.
- HYPERION DEFI, INC. net income (loss) attributable to parent for the quarter ending 2025-12-31 was -$39.77M.
- HYPERION DEFI, INC. net income (loss) attributable to parent for the quarter ending 2025-09-30 was $6.63M.
- HYPERION DEFI, INC. net income (loss) attributable to parent for fiscal 2022 was -$28.01M.
- HYPERION DEFI, INC. net income (loss) attributable to parent for fiscal 2021 was -$12.78M.
- HYPERION DEFI, INC. net income (loss) attributable to parent for fiscal 2020 was -$19.77M.
- HYPERION DEFI, INC. net income (loss) attributable to parent for fiscal 2019 was -$21.16M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $30.95M 10-Q · filed 2026-08-13 | $39.79M 10-Q · filed 2026-08-13 | $26.38K derived: sum of 3 quarters · filed 2026-08-13 | $6.65M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | $8.84M 10-Q · filed 2026-08-13 | -$30.92M derived: sum of 2 quarters · filed 2026-08-13 | -$24.30M derived: sum of 3 quarters · filed 2026-08-13 | -$32.99M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | -$39.77M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-05-05 | -$33.14M derived: sum of 2 quarters · filed 2026-05-05 | -$41.83M derived: sum of 3 quarters · filed 2026-08-13 | -$45.31M DEF 14A · filed 2026-05-05 | -$45.31M 10-K · filed 2026-03-30 |
| 2025-09-30 | $6.63M 10-Q · filed 2025-11-14 | -$2.07M derived: sum of 2 quarters · filed 2026-08-13 | -$5.55M 10-Q · filed 2025-11-14 | -$25.50M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | -$8.69M 10-Q · filed 2026-08-13 | -$12.17M 10-Q · filed 2026-08-13 | -$32.13M derived: sum of 3 quarters · filed 2026-08-13 | -$40.02M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | -$3.48M 10-Q · filed 2026-08-13 | -$23.44M derived: sum of 2 quarters · filed 2026-08-13 | -$31.33M derived: sum of 3 quarters · filed 2026-08-13 | -$42.38M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2024-12-31 | -$19.95M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-05-05 | -$27.84M derived: sum of 2 quarters · filed 2026-05-05 | -$38.90M derived: sum of 3 quarters · filed 2026-05-05 | -$49.82M DEF 14A · filed 2026-05-05 | -$49.82M 10-K · filed 2025-04-15 |
| 2024-09-30 | -$7.89M 10-Q · filed 2025-11-14 | -$18.94M derived: sum of 2 quarters · filed 2025-11-14 | -$29.86M 10-Q · filed 2025-11-14 | -$37.83M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-06-30 | -$11.05M 10-Q · filed 2025-11-14 | -$21.98M 10-Q · filed 2025-08-13 | -$29.94M derived: sum of 3 quarters · filed 2026-05-05 | -$37.28M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-03-31 | -$10.92M 10-Q · filed 2025-11-14 | -$18.89M derived: sum of 2 quarters · filed 2026-05-05 | -$26.23M derived: sum of 3 quarters · filed 2026-05-05 | -$32.44M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2023-12-31 | -$7.97M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-05-05 | -$15.31M derived: sum of 2 quarters · filed 2026-05-05 | -$21.52M derived: sum of 3 quarters · filed 2026-05-05 | -$27.26M DEF 14A · filed 2026-05-05 | -$27.26M 10-K · filed 2024-03-18 |
| 2023-09-30 | -$7.34M 10-Q · filed 2024-11-12 | -$13.55M derived: sum of 2 quarters · filed 2024-11-12 | -$19.29M 10-Q · filed 2024-11-12 | -$25.42M derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | -$6.22M 10-Q · filed 2024-11-12 | -$11.96M 10-Q · filed 2024-08-14 | -$18.08M derived: sum of 3 quarters · filed 2024-11-12 | -$25.39M derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-03-31 | -$5.74M 10-Q · filed 2024-11-12 | -$11.86M derived: sum of 2 quarters · filed 2024-11-12 | -$19.17M derived: sum of 3 quarters · filed 2024-11-12 | -$26.41M derived: sum of 4 quarters · filed 2024-11-12 | |
| 2022-12-31 | -$6.12M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | -$13.43M derived: sum of 2 quarters · filed 2024-03-18 | -$20.67M derived: sum of 3 quarters · filed 2024-03-18 | -$28.01M 10-K · filed 2024-03-18 | |
| 2022-09-30 | -$7.31M 10-Q · filed 2023-11-13 | -$14.55M derived: sum of 2 quarters · filed 2023-11-13 | -$21.89M 10-Q · filed 2023-11-13 | -$18.90M derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | -$7.24M 10-Q · filed 2023-11-13 | -$14.58M 10-Q · filed 2023-08-11 | -$11.60M derived: sum of 3 quarters · filed 2023-11-13 | -$17.16M derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-03-31 | -$7.34M 10-Q · filed 2023-11-13 | -$4.36M derived: sum of 2 quarters · filed 2023-11-13 | -$9.92M derived: sum of 3 quarters · filed 2023-11-13 | -$14.77M derived: sum of 4 quarters · filed 2023-11-13 | |
| 2021-12-31 | $2.98M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$2.59M derived: sum of 2 quarters · filed 2023-03-31 | -$7.43M derived: sum of 3 quarters · filed 2023-03-31 | -$12.78M 10-K · filed 2023-03-31 | |
| 2021-09-30 | -$5.57M 10-Q · filed 2022-11-14 | -$10.41M derived: sum of 2 quarters · filed 2022-11-14 | -$15.76M 10-Q · filed 2022-11-14 | -$19.97M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | -$4.84M 10-Q · filed 2022-11-14 | -$10.19M 10-Q · filed 2022-08-11 | -$14.40M derived: sum of 3 quarters · filed 2022-11-14 | -$19.50M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-03-31 | -$5.35M 10-Q · filed 2022-11-14 | -$9.56M derived: sum of 2 quarters · filed 2022-11-14 | -$14.66M derived: sum of 3 quarters · filed 2022-11-14 | -$19.67M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2020-12-31 | -$4.21M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$9.30M derived: sum of 2 quarters · filed 2022-03-30 | -$14.32M derived: sum of 3 quarters · filed 2022-03-30 | -$19.77M 10-K · filed 2022-03-30 | |
| 2020-09-30 | -$5.10M 10-Q · filed 2021-11-12 | -$10.11M derived: sum of 2 quarters · filed 2021-11-12 | -$15.56M 10-Q · filed 2021-11-12 | -$20.80M derived: sum of 4 quarters · filed 2021-11-12 | |
| 2020-06-30 | -$5.02M 10-Q · filed 2021-11-12 | -$10.47M 10-Q · filed 2021-08-12 | -$15.71M derived: sum of 3 quarters · filed 2021-11-12 | -$20.36M derived: sum of 4 quarters · filed 2021-11-12 | |
| 2020-03-31 | -$5.45M 10-Q · filed 2021-11-12 | -$10.69M derived: sum of 2 quarters · filed 2021-11-12 | -$15.34M derived: sum of 3 quarters · filed 2021-11-12 | -$20.68M derived: sum of 4 quarters · filed 2021-11-12 | |
| 2019-12-31 | -$5.24M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | -$9.89M derived: sum of 2 quarters · filed 2021-03-30 | -$15.22M derived: sum of 3 quarters · filed 2021-03-30 | -$21.16M 10-K · filed 2021-03-30 | |
| 2019-09-30 | -$4.65M 10-Q · filed 2020-11-12 | -$9.98M derived: sum of 2 quarters · filed 2020-11-12 | -$15.92M 10-Q · filed 2020-11-12 | -$22.10M derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | -$5.33M 10-Q · filed 2020-11-12 | -$11.27M 10-Q · filed 2020-08-14 | -$17.45M derived: sum of 3 quarters · filed 2020-11-12 | -$21.77M derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-03-31 | -$5.93M 10-Q · filed 2020-11-12 | -$12.12M derived: sum of 2 quarters · filed 2020-11-12 | -$16.44M derived: sum of 3 quarters · filed 2020-11-12 | -$19.76M derived: sum of 4 quarters · filed 2020-11-12 | |
| 2018-12-31 | -$6.18M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$10.50M derived: sum of 2 quarters · filed 2020-03-30 | -$13.82M derived: sum of 3 quarters · filed 2020-03-30 | -$17.25M 10-K · filed 2020-03-30 | |
| 2018-09-30 | -$4.32M 10-Q · filed 2019-11-13 | -$7.64M derived: sum of 2 quarters · filed 2019-11-13 | -$11.07M 10-Q · filed 2019-11-13 | -$13.23M derived: sum of 4 quarters · filed 2019-11-13 | |
| 2018-06-30 | -$3.32M 10-Q · filed 2019-11-13 | -$6.75M 10-Q · filed 2019-08-13 | -$8.91M derived: sum of 3 quarters · filed 2019-11-13 | -$9.80M derived: sum of 4 quarters · filed 2019-11-13 | |
| 2018-03-31 | -$3.43M 10-Q · filed 2019-11-13 | -$5.59M derived: sum of 2 quarters · filed 2019-11-13 | -$6.48M derived: sum of 3 quarters · filed 2019-11-13 | -$7.45M derived: sum of 4 quarters · filed 2019-11-13 | |
| 2017-12-31 | -$2.16M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-27 | -$3.05M derived: sum of 2 quarters · filed 2019-03-27 | -$4.02M derived: sum of 3 quarters · filed 2019-03-27 | -$5.13M 10-K · filed 2019-03-27 | |
| 2017-09-30 | -$884.62K 10-Q · filed 2018-11-13 | -$1.86M derived: sum of 2 quarters · filed 2018-11-13 | -$2.97M 10-Q · filed 2018-11-13 | ||
| 2017-06-30 | -$976.59K 10-Q · filed 2018-08-14 | -$2.08M 10-Q · filed 2018-08-14 | |||
| 2017-03-31 | -$1.11M 10-Q · filed 2018-05-09 | ||||
| 2016-12-31 | -$3.53M 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |